Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of GlucoCEST MRI as a Biomarker in Cancer Translational Study

NCT03212157 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT03212157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03212157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of GlucoCEST MRI as a Biomarker in Cancer Translational Study
Lead sponsor
University College, London
Phase
Not applicable
Overall status
Completed
Start date
January 6, 2017
Completion date
October 8, 2019
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma, head and neck squamous cell carcinoma, lymphoma